Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Fisherman

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Biochemical Pharmacology|June 15, 1979
Action of sulfhydryl reagents on cholinergic mechanisms in synaptosomesA Baba, J S Fisherman, J R Cooper
Seminars in Oncology|October 1, 1994
Combination paclitaxel (Taxol) and doxorubicin therapy for metastatic breast cancerJ A O'Shaughnessy, J S Fisherman, K H Cowan
Investigational New Drugs|November 1, 1991
Terephthalamidine: past and futureJ S Fisherman, E M Cline, J Plowman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Cardiac disturbances during the administration of taxolE K Rowinsky, W P McGuire, T Guarnieri, et al.
Cancer|March 1, 1993
Typhlitis resulting from treatment with taxol and doxorubicin in patients with metastatic breast cancerB C Pestalozzi, G A Sotos, P L Choyke, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1993
Phase I study of Taxol, doxorubicin, plus granulocyte-colony stimulating factor in patients with metastatic breast cancerJ S Fisherman, M McCabe, M Noone, et al.
Investigational New Drugs|February 1, 1993
Chloroquinoxaline sulfonamide: a sulfanilamide antitumor agent entering clinical trialsJ S Fisherman, B L Osborn, H G Chun, et al.
Journal of the National Cancer Institute|January 19, 1994
Pharmacokinetics of taxol and doxorubicin administered alone and in combination by continuous 72-hour infusionS L Berg, K H Cowan, F M Balis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103E L Trimble, J D Adams, D Vena, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1993
Clinical development of TaxolS G Arbuck, M C Christian, J S Fisherman, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Biochemical Pharmacology|June 15, 1979
Action of sulfhydryl reagents on cholinergic mechanisms in synaptosomesA Baba, J S Fisherman, J R Cooper
Seminars in Oncology|October 1, 1994
Combination paclitaxel (Taxol) and doxorubicin therapy for metastatic breast cancerJ A O'Shaughnessy, J S Fisherman, K H Cowan
Investigational New Drugs|November 1, 1991
Terephthalamidine: past and futureJ S Fisherman, E M Cline, J Plowman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Cardiac disturbances during the administration of taxolE K Rowinsky, W P McGuire, T Guarnieri, et al.
Cancer|March 1, 1993
Typhlitis resulting from treatment with taxol and doxorubicin in patients with metastatic breast cancerB C Pestalozzi, G A Sotos, P L Choyke, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1993
Phase I study of Taxol, doxorubicin, plus granulocyte-colony stimulating factor in patients with metastatic breast cancerJ S Fisherman, M McCabe, M Noone, et al.
Investigational New Drugs|February 1, 1993
Chloroquinoxaline sulfonamide: a sulfanilamide antitumor agent entering clinical trialsJ S Fisherman, B L Osborn, H G Chun, et al.
Journal of the National Cancer Institute|January 19, 1994
Pharmacokinetics of taxol and doxorubicin administered alone and in combination by continuous 72-hour infusionS L Berg, K H Cowan, F M Balis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103E L Trimble, J D Adams, D Vena, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1993
Clinical development of TaxolS G Arbuck, M C Christian, J S Fisherman, et al.
Pageof 2